Rwanda FDA advocates for rational drug use to prevent antimicrobial resistance crisis

Lazare Ntirenganya (right), the Division Manager for Pharmacovigilance and Clinical Trials at Rwanda FDA, explains the steps needed to safeguard public health.
Lazare Ntirenganya (right), the Division Manager for Pharmacovigilance and Clinical Trials at Rwanda FDA, explains the steps needed to safeguard public health.
Joan Mbabazi